|
Prospect Biosystems, Inc. |
|
|
Center III, 211 Warren Street Newark, NJ 07103 USA phone:(973) 242-6500 x103 fax:(973) 215-2558
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.prospectbiosys.com
|
|
| Research Sector |
Healthcare Services |
|
 |
| Summary Description |
| Prospect Biosystems is an innovative developer and provider of products uniquely serving the Sample Preparation needs of the Proteomics market. Our products provide up-stream sample processing and are complementary to existing analytical instrumentation. |
 |
| Management |
| Marc Horn-President & CEO |
|
|
| |
| Keywords |
| innovative developer, Proteomics, analytical instrumentation, sample preparation |
|
|
|
|
|
| Description |
|
Prospect Biosystems is a technology-driven proteomics company with a broad-range biomarker discovery capability and instrumentation platform,
providing rapid biology-based fractionation of complex tissue and cell samples,
leading to accelerated pharmaceutical discovery, development and commercialization. |
 |
| Products / Services |
The Company's initial focus has been the development of instrumentation and reagents to perform and optimize the Edge technology for users doing analytical proteomics research and biomarker discovery.
Additionally, we have identified opportunities for our instrumentation products in the areas of clinical diagnostics, clinical trials, and pathological evaluation.
|
 |
| Technology / Differentiation |
Prospect Biosystems Edge Systems address the market's needs in the following areas:
-Biomarker discovery
-Low abundance protein isolation and enrichment
-Biological information on subcellular location
-Subcellular biology, cell biology and subcellular proteomics
-Drug target discovery and characterization
-Binding studies and protein-protein interactions
|
 |
| Market / Customers |
Prospect Biosystem's customers are engaged in analytical proteomics, biomarker discovery, clinical diagnostics and surgical pathology.
|
 |
|
|
|
|